Bone Biologics Corp

Common Stock SEC Reporting - Current
Verified Company Profile 10/10/2016
Contact Info
  • 321 Columbus Ave
  • Boston, MA 02116

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001419554
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3842 - Surgical appliances and supplies
Business Status Development Stage Company a/o Dec 31, 2015
Incorporated In: DE, USA
Year of Inc. 2007
Employees 3 a/o Oct 05, 2016
Company Officers/Contacts
Stephen LaNeve CEO
Jeffrey Frelick COO
Deina Walsh CFO
Company Directors
Bruce Stroever Chairman
John Booth
William Coffin
Jimmy Deshland
Bessie Soo
Ben Wu
Service Providers
Accounting/Auditing Firm
Anton & Chia LLP
3501 Jamboree Rd.,
STE 540
Newport Beach, CA, 92660
United States

Legal Counsel
TroyGould PC
1801 Century Park East
Suite 1600
Los Angeles, CA, 90067-2367
United States

Investor Relations Firm
Not Available
BBLG Security Details
Share Structure
Market Value1 $139,782,985 a/o Oct 26, 2016
Authorized Shares 100,000,000 a/o Mar 29, 2016
Outstanding Shares 38,828,607 a/o Aug 05, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s)
Corporate Stock Transfer, Inc.
Shareholders of Record 36 a/o Mar 29, 2016
Short Selling Data
Short Interest (%)
Significant Failures to Deliver No

1Market Value calculated only for respective security